Anthrax is a zoonotic disease with a global distribution that causes catastrophic outbreaks in livestock, wildlife, and frequently endangered species. The commercially available animal vaccine is only effective as a subcutaneous injection which is not practical for use in free-ranging livestock and wildlife. This project will build upon our previous successful oral vaccine research by evaluating a novel oral anthrax vaccine formulation in a target animal model commonly affected by anthrax.